Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCity Lon Inv Regulatory News (CLIG)

Share Price Information for City Lon Inv (CLIG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 380.00
Bid: 370.00
Ask: 379.00
Change: 15.00 (4.11%)
Spread: 9.00 (2.432%)
Open: 356.00
High: 380.00
Low: 356.00
Prev. Close: 365.00
CLIG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

17 Jan 2018 07:00

RNS Number : 0648C
City of London Investment Group PLC
17 January 2018
 

RNS Number:

City of London Investment Group PLC

17 January 2018



CITY OF LONDON INVESTMENT GROUP PLC

("City of London", "the Group" or "the Company")

 

FUNDS UNDER MANAGEMENT AS AT 31 December 2017,

TRADING UPDATE

 

City of London (LSE: CLIG) announces that total funds under management (FuM) at the Group's half year on 31 December 2017 were US$5.3 billion (£3.9 billion). This compares with US$4.7 billion (£3.6 billion) at the Company's year-end on 30 June 2017. A breakdown by strategy follows:

 

FuM ($mn)

Strategy Index

Jun-17

Dec-17

% inc /

Net

% inc /

(estimate)

dec

Flows

dec

EM

4,202

4,660

11%

(89)

MSCI EM

16%

DEV

179

337

88%

129

MSCI ACWI

11%

GTAA

110

139

26%

20

ACWI/Barclays Global Agg

7%

Frontier

172

193

12%

2

MSCI Frontier

12%

4,663

5,329

62

 

 

Positive relative investment performance was recorded across Developed, GTAA and Frontier strategies. Generally, a combination of strong NAV performance, discount narrowing and opportunistic participation in event driven US situations drove relative performance. The EM strategy underperformed due to widening discounts and an underweight to the Chinese IT sector which posted very strong returns. Net flows were positive in aggregate over the period, particularly in the Developed strategy which continues to benefit from a focused marketing strategy and excellent long term investment results.

 

In addition, we have to date received notification of $110 million net inflows in aggregate across all strategies, which we expect to fund over the next quarter.

 

With regards to business development, the Group continues to maintain an active pipeline across all of its major CEF offerings with an increased interest in the diversification CEF strategies. In total the active pipeline is in excess of US$400 million, these include opportunities that are spread across Emerging and Developed Markets, Global Tactical Asset Allocation, Tactical Income, and Frontier CEF strategies.

 

Operations

 

The Group's income currently accrues at a weighted average rate of approximately 82 basis points of FuM, net of third party commissions. "Fixed" costs are c£1.0 million per month, and accordingly the current run-rate for operating profit, before profit-share of 30% and an estimated EIP charge of 2%, is approximately £1.7 million per month based upon current FuM and a US$/£ exchange rate of US$1.35 to £1 as at 31 December 2017.

 

The Group estimates the unaudited profit before taxation for the six months ended 31 December 2017 to be approximately £6.6 million, which compares with £5.8 million for the equivalent period to 31 December 2016.

 

The Company is currently in a close period which will end with the publication of results for the six months ended 31 December 2017 on 19 February 2018.

 

Dividend

 

The Board has decided to declare an interim dividend of 9 pence (2017: 8 pence). The dividend will be paid on 16 March 2018 to shareholders registered at the close of business on 2 March 2018.

 

 

Template

 

Please see the attached graph which is based on the following assumptions and includes the estimated quarterly cost of a maintained dividend:

 

http://www.rns-pdf.londonstockexchange.com/rns/0648C_1-2018-1-16.pdf

 

Key assumptions:

 

(June 2017 comparatives in Italics)

· Starting point Current FuM (end December 2017)

· Net increase for the remainder of this financial year (straight-lined to June 2018):

- emerging market CEF strategy US$100m (US$250m over full year)

- non-emerging market CEF strategies US$125 (US$250m over full year)

· Net increase in 2018/2019 (straight-lined to June 2019):

- emerging market CEF strategy US$100m

- non-emerging market CEF strategies US$250m

· Operating margin adjusted monthly for change in product mix and commission run-off

· Market growth: 0%

· Overheads for 2017/18: +4% compared to 2016/17 (+3%)

· Overheads for 2018/19: +7% compared to 2016/17

· EIP cost for 2017/18: 2% of operating profit (2%)

· EIP cost for 2018/19: 4% of operating profit

· Corporation tax based on an estimated average rate of 23% (23%)

· Exchange rate assumed to be £1/$1.35 for entire period (£1/US$1.30)

· Number of CLIG Shares in issue (26.9m) less those held by the ESOP Trust (1.4m) as at 31 December (26.9m CLIG shares in issue less 1.5m ESOP Trust holding)

 

For further information, please visit http://www.citlon.co.uk/ or contact:

 

Barry Olliff, CEO

City of London Investment Group PLC

Tel: 001 215 313 3774

 

Martin Green

Zeus Capital Limited

Financial Adviser & Broker

Tel: +44 (0)20 3829 5000

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTSFUFAMFASEDF
Date   Source Headline
22nd Sep 201711:08 amRNSHolding(s) in Company
18th Sep 20177:00 amRNSFinal Results
8th Sep 20177:53 amRNSDirector/PDMR Shareholding
31st Aug 20174:00 pmRNSOpen letter to the board of icapital.biz Berhad
20th Jul 20176:22 pmRNSHolding(s) in Company
19th Jul 20177:00 amRNSTrading Update
13th Jul 20176:15 pmRNSHolding(s) in Company
13th Jul 20177:00 amRNSChange of announcement date
13th Jun 20174:26 pmRNSBoard Changes
26th May 20173:49 pmRNSDirector/PDMR Shareholding
25th May 20172:12 pmRNSDirector/PDMR Shareholding
22nd May 201712:56 pmRNSHolding(s) in Company
8th May 20176:03 pmRNSShare Buyback and Total Voting Rights
26th Apr 20173:37 pmRNSHolding(s) in Company
18th Apr 20171:56 pmRNSDirector/PDMR Shareholding
11th Apr 20177:00 amRNSTrading Update
3rd Apr 201712:42 pmRNSHolding(s) in Company
24th Mar 20172:28 pmRNSHolding(s) in Company
21st Mar 20175:20 pmRNSHolding(s) in Company
22nd Feb 20171:40 pmRNSDirector/PDMR Shareholding
22nd Feb 20171:37 pmRNSDirector/PDMR Shareholding
20th Feb 20177:46 amRNSHALF YEAR RESULTS TO 31ST DECEMBER 2016
24th Jan 20173:24 pmRNSHardman Research:Q2 statement robust profitability
17th Jan 20177:00 amRNSFunds Under Management - Trading Update
24th Nov 20163:42 pmRNSDirector/PDMR Shareholding
19th Oct 201611:15 amRNSAGM resolutions
17th Oct 20165:49 pmRNSResult of AGM
13th Oct 20163:05 pmRNSDirector/PDMR Shareholding
11th Oct 20165:13 pmRNSHolding(s) in Company
11th Oct 20162:51 pmRNSDirector/PDMR Shareholding
10th Oct 20167:46 amRNSAGM Trading Update - 1st Qtr Funds under Mgmt
15th Sep 20169:46 amRNSLetter to icapital.biz Berhad
14th Sep 20169:32 amRNSHardman Report: Exchange rate moves give big boost
12th Sep 20167:00 amRNSFINAL RESULTS FOR THE YEAR TO 30TH JUNE 2016
18th Jul 20167:00 amRNSTrading Update
1st Jul 20167:00 amRNSBlock listing cancellation & block listing return
30th Jun 20164:40 pmRNSSecond Price Monitoring Extn
30th Jun 20164:35 pmRNSPrice Monitoring Extension
23rd Jun 20165:55 pmRNSDirector/PDMR Shareholding
14th Apr 201612:38 pmRNSHardman & Co Issues Research Report
22nd Feb 201611:18 amRNSDirector/PDMR Shareholding
15th Feb 20167:00 amRNSHalf Yearly Report
5th Feb 20164:40 pmRNSSecond Price Monitoring Extn
5th Feb 20164:35 pmRNSPrice Monitoring Extension
29th Jan 20164:41 pmRNSSecond Price Monitoring Extn
29th Jan 20164:35 pmRNSPrice Monitoring Extension
27th Jan 20164:40 pmRNSSecond Price Monitoring Extn
27th Jan 20164:35 pmRNSPrice Monitoring Extension
13th Jan 20169:57 amRNSHardman Issues Research Report
12th Jan 20167:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.